miR-320d Is Associated with Reduced Nasopharyngeal Carcinoma Progression, Potentially through the NF-κB/IL-8

Liu Liu1,2, Jie Liu1,2, Shuangchen Ning3

  • 1The First Hospital of Hunan University of Chinese Medicine, Changsha, China.

Oncology Research
|July 25, 2026
PubMed

Insights

MicroRNA-320d (miR-320d) suppresses nasopharyngeal carcinoma (NPC) progression by inhibiting neutrophil extracellular trap (NET) formation via the nuclear factor kappa-B (NF-κB)/interleukin-8 (IL-8) pathway. This highlights a potential therapeutic target for NPC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high recurrence and metastasis rates.
  • MicroRNAs (miRNAs) are crucial in post-transcriptional gene regulation and tumor progression.
  • The specific role of miR-320d in NPC and its connection to neutrophil extracellular trap (NET) formation is not well understood.

Purpose of the Study:

  • To investigate the biological role of miR-320d in NPC.
  • To determine if miR-320d regulates NET formation through the nuclear factor kappa-B (NF-κB)/interleukin-8 (IL-8) signaling axis.

Main Methods:

  • Overexpression of miR-320d in NPC cell lines (S18 and 5-8F).
  • Assessment of cell viability, migration, and invasion.
  • Integrated transcriptomic and proteomic analyses.
  • Validation of NET-associated proteins and NF-κB/IL-8 signaling components via Western blotting, immunohistochemistry, and immunofluorescence.

Main Results:

  • miR-320d overexpression significantly inhibited NPC cell viability, migration, and invasion.
  • Multi-omics analysis revealed enrichment of NET-related pathways regulated by miR-320d.
  • miR-320d reduced the expression of key NET proteins (GP1BA, HDAC10, FGG, PADI4, MPO, NE) and suppressed NF-κB signaling, decreasing p-NF-κB and IL-8 secretion.

Conclusions:

  • miR-320d suppresses NPC progression, partly by attenuating NF-κB/IL-8-associated NET formation.
  • The miR-320d/NF-κB/IL-8/NET regulatory axis is implicated in NPC progression.
  • Further translational research into this axis as a potential therapeutic strategy for NPC is warranted.